+Search query
-Structure paper
| Title | Natural Asp-tRNA Synthetase Fragment Targets Myofibroblasts to Abrogate Tissue Fibrosis. |
|---|---|
| Journal, issue, pages | J Biol Chem, Page 113586, Year 2026 |
| Publish date | Sep 30, 2026 |
Authors | Ryan A Adams / Ying-Ting Wang / Alison G Barber / Kristina Hamel / Andrew Imfeld / Luke Burman / Kaitlyn Rauch / Yeeting E Chong / Angelica Villanueva / Lauren Guy / Wayne Liu / Crystal Manzo / Sofia Klopp-Savino / Clara Polizzi / Jasmine Stamps / Max Pastenes / Honglei Tian / Chun Po Fung / Yingyi Zhang / Kwok Wa Hugo Ho / Bruno Sangiorgi / Blythe Dillingham / Tarsis F Brust / Kyle P Chiang / Zhenguo Wu / Zhiwen Xu / Christoph Burkart / Leslie A Nangle / ![]() |
| PubMed Abstract | Fibrosis remains a major global health challenge with limited therapies that only slow disease progression. While the aminoacyl-tRNA synthetase (aaRS) family is known to utilize evolutionarily ...Fibrosis remains a major global health challenge with limited therapies that only slow disease progression. While the aminoacyl-tRNA synthetase (aaRS) family is known to utilize evolutionarily appended domains as extracellular signaling molecules, their role in regulating the homeostasis of the fibrotic process is poorly defined. We identify a natural proteolytic fragment of aspartyl-tRNA synthetase (DARS), termed DARS-N1, that selectively triggers apoptosis in myofibroblasts by targeting latent-transforming growth factor beta binding protein 1 (LTBP-1) on the extracellular matrix (ECM). This active N-terminal fragment of DARS reduces focal adhesion kinase (FAK) activation in undifferentiated fibroblasts and myofibroblasts, while only myofibroblasts exhibit inadequate cell-matrix attachment leading to loss of anchorage-dependent survival and promotion of apoptosis. We utilized ATYR0101, a therapeutic form of DARS-N1 engineered for extended serum exposure, to demonstrate anti-fibrotic activity in lung (bleomycin). Spatial transcriptomics analysis showed that ATYR0101 activates a restorative program promoting the return to a healthy state. These findings highlight ATYR0101's potential as a transformative therapy for disrupting the process of chronic tissue fibrosis. |
External links | J Biol Chem / PubMed:42815638 |
| Methods | EM (single particle) |
| Resolution | 4.96 Å |
| Structure data | EMDB-67441, PDB-21aa: |
| Source |
|
Keywords | APOPTOSIS / Fibrosis / t-RNA synthase / Myofibroblast |
Movie
Controller
Structure viewers
About Yorodumi Papers



Authors

External links

homo sapiens (human)
Keywords